David Rowlands

Company: AstraZeneca

Job title: Global Project Leader, early Respiratory and Immunology Research and development

Seminars:

Panel Discussion: Unravelling the Rationale Behind Combination Therapy & Critical Design & Development Considerations for Emerging Therapeutic Candidates 3:15 pm

• Exploring the current limitations of single agent therapeutics and the scientific rationale behind targeting multiple pathways and processes for enhanced efficacy in halting fibrosis • Critical considerations into clinical trial design in combination therapy including patient population selection based on specific signatures predicting a better response to combination • Defining appropriate endpoints for combination…Read more

day: Day Two